Systemic lupus erythematosus: recent developments.
Marmont
A M
AM
Cerri
R
R
Giordano
D
D
Risso
M
M
Cantú
L
L
Grassia
L
L
Queirolo
A
A
Raffo
M R
MR
D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000276:immunology*; D000974:Antibodies, Antinuclear / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000276:immunology*; D010951:Plasma Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology; D015996:Survival Rate
D000906:Antibodies; D000974:Antibodies, Antinuclear; D010743:Phospholipids; D003520:Cyclophosphamide